RECURSION PHARMACEUTICALS Trademark

Trademark Overview


On Thursday, March 2, 2017, a trademark application was filed for RECURSION PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the RECURSION PHARMACEUTICALS trademark a serial number of 87356048. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 3, 2024. This trademark is owned by Recursion Pharmaceuticals, Inc.. The RECURSION PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development services; Scientific research and development of pharmaceutical preparations; Pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; Contract research services in support of scientific research and development of pharmaceutical preparations; Technical consultancy and services in relation to technical research in the field of pharmaceuticals; Consultancy in relation to scientific research in the field of pharmaceuticals; Providing medical research and scientific research information in the field of medicine and pharmaceuticals; Drug discovery services; Drug use discovery services
recursion pharmaceuticals

General Information


Serial Number87356048
Word MarkRECURSION PHARMACEUTICALS
Filing DateThursday, March 2, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 3, 2024
Registration Number5310303
Registration DateTuesday, October 17, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 1, 2017

Trademark Statements


Description of MarkThe mark consists of an image of a hexagon with a portion cutout, separated from the words "RECURSION PHARMACEUTICALS" by a vertical line.
Certificate of Correction for RegistrationIn the statement, line 1, "UTAH" should be deleted, and "DELAWARE" should be inserted.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMACEUTICALS"
Goods and ServicesPharmaceutical research and development services; Scientific research and development of pharmaceutical preparations; Pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; Contract research services in support of scientific research and development of pharmaceutical preparations; Technical consultancy and services in relation to technical research in the field of pharmaceuticals; Consultancy in relation to scientific research in the field of pharmaceuticals; Providing medical research and scientific research information in the field of medicine and pharmaceuticals; Drug discovery services; Drug use discovery services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 3, 2024
Primary Code042
First Use Anywhere DateSaturday, November 16, 2013
First Use In Commerce DateSaturday, November 16, 2013

Trademark Owner History


Party NameRecursion Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84101

Party NameRecursion Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108

Party NameRecursion Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84101

Trademark Events


Event DateEvent Description
Monday, March 6, 2017NEW APPLICATION ENTERED
Thursday, March 9, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 10, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 25, 2017ASSIGNED TO EXAMINER
Saturday, May 27, 2017PRIORITY ACTION WRITTEN
Saturday, May 27, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Saturday, May 27, 2017PRIORITY ACTION E-MAILED
Wednesday, June 7, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, June 7, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 7, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, June 7, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 12, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 1, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 1, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, January 21, 2021TEAS SECTION 7 REQUEST RECEIVED
Monday, June 7, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, February 16, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 26, 2021POST REGISTRATION ACTION MAILED - SEC. 7
Monday, June 7, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, June 9, 2021CORRECTION UNDER SECTION 7 - PROCESSED
Friday, May 3, 2024CANCELLED SEC. 8 (6-YR)
Monday, October 17, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED